Zurcher Kantonalbank (Zurich Cantonalbank) Acadia Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 30,501 shares of ACAD stock, worth $664,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,501

Previous 27,256 11.91%

Holding current value

$664,921

Previous $452,000 45.35%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$14.1 - $22.95 $45,754 - $74,472	3,245 Added 11.91%	30,501 $657,000
Q1 2025 May 07, 2025	BUY	$16.61 - $20.29 $56,291 - $68,762	3,389 Added 14.2%	27,256 $452,000
Q4 2024 Feb 07, 2025	SELL	$14.29 - $18.76 $1,386 - $1,819	-97 Reduced 0.4%	23,867 $437,000
Q3 2024 Nov 07, 2024	SELL	$15.14 - $19.14 $151 - $191	-10 Reduced 0.04%	23,964 $368,000
Q2 2024 Jul 29, 2024	SELL	$14.62 - $18.42 $233 - $294	-16 Reduced 0.07%	23,974 $389,000
Q1 2024 Apr 25, 2024	BUY	$17.79 - $30.86 $10,407 - $18,053	585 Added 2.5%	23,990 $443,000
Q3 2023 Oct 25, 2023	BUY	$20.84 - $33.47 $53,100 - $85,281	2,548 Added 12.22%	23,405 $487,000
Q2 2023 Aug 07, 2023	BUY	$17.8 - $25.65 $65,575 - $94,494	3,684 Added 21.45%	20,857 $499,000
Q1 2023 May 08, 2023	SELL	$16.32 - $20.92 $12,337 - $15,815	-756 Reduced 4.22%	17,173 $323,000
Q4 2022 Feb 01, 2023	BUY	$14.2 - $18.63 $40,228 - $52,778	2,833 Added 18.77%	17,929 $285,000
Q2 2022 Aug 09, 2022	SELL	$13.01 - $27.22 $36,831 - $77,059	-2,831 Reduced 15.79%	15,096 $213,000
Q1 2022 Apr 21, 2022	BUY	$20.94 - $27.5 $27,933 - $36,685	1,334 Added 8.04%	17,927 $434,000
Q4 2021 Feb 01, 2022	BUY	$16.79 - $27.09 $58,748 - $94,787	3,499 Added 26.72%	16,593 $387,000
Q1 2021 May 03, 2021	SELL	$25.02 - $54.99 $40,006 - $87,929	-1,599 Reduced 10.88%	13,094 $338,000
Q4 2020 Jan 28, 2021	BUY	$41.04 - $56.79 $61,806 - $85,525	1,506 Added 11.42%	14,693 $785,000
Q2 2020 Jul 28, 2020	BUY	$39.26 - $52.73 $115,699 - $155,395	2,947 Added 28.78%	13,187 $639,000
Q1 2020 May 06, 2020	BUY	$31.65 - $46.87 $78,428 - $116,143	2,478 Added 31.92%	10,240 $433,000
Q4 2019 Jan 21, 2020	BUY	$36.21 - $51.4 $49,426 - $70,161	1,365 Added 21.34%	7,762 $332,000
Q1 2019 Apr 29, 2019	SELL	$16.17 - $27.38 $24,869 - $42,110	-1,538 Reduced 19.38%	6,397 $172,000
Q4 2018 Jan 25, 2019	BUY	$14.32 - $22.92 $32,105 - $51,386	2,242 Added 39.38%	7,935 $128,000
Q1 2018 May 03, 2018	SELL	$22.47 - $32.33 $38,423 - $55,284	-1,710 Reduced 23.1%	5,693 $128,000
Q4 2017 Jan 31, 2018	BUY	$26.84 - $39.14 $46,513 - $67,829	1,733 Added 30.56%	7,403 $223,000
Q3 2017 Nov 08, 2017	BUY	$29.49 - $38.37 $167,208 - $217,557	5,670	5,670 $214,000

Others Institutions Holding ACAD

# of Institutions

346

Shares Held

165M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.53B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Acadia Pharmaceuticals Inc Transaction History